Vaxcyte (PCVX) COO Wassil Jim Sells Shares, Exercises Options

What Happened

• Wassil Jim, Chief Operating Officer of Vaxcyte, exercised options on 2026-09-01 (2,250 shares at $5.35, cost $12,038) and concurrently disposed of a total of 6,182 shares between 2026-08-31 and 2026-09-02. The disposals include open-market sales (3,477 shares, ~$212,351) and shares surrendered to cover tax withholding on vested awards (2,705 shares, ~$165,505). Combined reported proceeds and share-withholding value total about $377,856. One derivative line shows 2,250 shares with $0 reported consideration (see Key Details).

Key Details

• Transaction dates and amounts:
  • 2026-08-31: 1,273 shares surrendered for tax withholding at $60.74 (value $77,322). (Footnote F1)
  • 2026-09-01: Exercised options — 2,250 shares at $5.35 (acquired) for $12,038. (Code M)
  • 2026-09-01: Open-market sales — 1,537 @ $60.89 ($93,582); 713 @ $61.48 ($43,836); 924 @ $60.95 ($56,322); 303 @ $61.42 ($18,611). (Code S)
  • 2026-09-01: A derivative/option line reports 2,250 shares disposed at $0.00 (reported $0). (Code M / see note)
  • 2026-09-02: 1,432 shares surrendered for tax withholding at $61.58 (value $88,183). (Footnote F1)
• Totals reported in this filing excerpt: 6,182 shares disposed (3,477 open-market + 2,705 tax-withheld), roughly $377,856 in proceeds/withholding value; 2,250 shares acquired by exercise for $12,038.
• Sales were effected pursuant to a Rule 10b5-1 trading plan adopted Dec 9, 2025 (Footnote F2).
• Reported sale prices are weighted averages; price ranges across the sales are noted in the filing (Footnotes F3–F6).
• Stock option referenced as fully vested and exercisable (Footnote F7).
• Shares owned after the transactions are not specified in the provided excerpt — see the Form 4 for the post-transaction beneficial ownership line.
• Filing date: 2026-09-02 for reporting period 2026-08-31 — appears timely (Form 4 is normally due within two business days).

Context

• This filing shows an option exercise (M) and multiple sales (S) including share-withholding to satisfy tax obligations (F). The combination of exercise and immediate sales/withholding is commonly used to cover exercise costs and taxes (sometimes called a cashless or net settlement), but the filing itself does not state motives. The open-market sales were processed under a pre-existing 10b5-1 plan, which organizes scheduled insider sales and can indicate routine disposition rather than spontaneous trading.

If you want, I can pull the exact Form 4 text or calculate per-share averages and totals with or without the tax-withheld shares included.